Allied Market Research has published a study report with the title U.S. Pharmacogenomics Market Size was valued at USD 2,463.9 Million in 2021 and is Anticipated to reach USD 5,676.1 Million by 2031, registering a CAGR of 8.7% from 2022 to 2031.
This report provides a comprehensive overview of the U.S. Pharmacogenomics Market, including an in-depth analysis of market trends, key segments, investment opportunities, value chain analysis, regional landscape, and competitive scenarios. It offers valuable insights for established market players, new entrants, investors, and other stakeholders to devise effective strategies and make informed decisions to enhance their market position. The report is a valuable resource for anyone seeking to gain a deeper understanding of the U.S. Pharmacogenomics Market and its growth potential in the future.
| Β Surge in number of key players who manufacture pharmacogenomic drugs and rise in adoption of key strategies such as partnership, agreement, acquisition, and business expansion by key players act as the key driving forces for growth of the U.S. pharmacogenomics market. For instance, in May 2020, Admera Health, a biotechnology research company announced partnership with Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare providers and patients to effectively manage genomic testing This important and strategic partnership allows Hygea to offer its customers high quality tests from Admera Health, such as PGxOne Plus for pharmacogenomics. Moreover, rise in application of pharmacogenomics in cardiovascular disease, infectious diseases, oncology, neurological diseases, and psychiatry drives the market growth. |
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/47832
Market Overview:
Pharmacogenomics, also known as pharmacogenetics, is a branch of genomic medicine that uses a patient’s genetic makeup to customize medications they receive. Pharmacogenomics promises to offer a more customized (or exact) approach to the use of readily available medications in treating patients in this way. Polymerase chain reaction (PCR), microarray, deoxyribonucleic acid (DNA) sequencing, mass spectrometry, and electrophoresis are only a few of the technologies used in pharmacogenomics. Pharmacogenomics uses genetic testing to assess effectiveness of recently produced medications as well as the likelihood that a patient would develop a particular disease.
β ππ¨π© ππ ππ‘ππ«π¦πππ¨π ππ§π¨π¦π’ππ¬ ππ¨π¦π©ππ§π’ππ¬
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN
- Agilent Technologies, Inc.
- Eurofins Scientific
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- Myriad Genetics, Inc.
β Β ππ ππ‘ππ«π¦πππ¨π ππ§π¨π¦π’ππ¬ πππ«π€ππ πππ π¦ππ§ππππ’π¨π§: β
The pharmacogenomics market can be segmented based on technology, application, end-user, and region. Hereβs a brief overview:
By Technology
- Next Generation Sequencing
- Polymerase Chain Reaction
- Gel Electrophoresis
- Mass Spectrometry
- Microarray
- Others
By Application
- Cardiovascular Diseases
- Infectious Diseases
- Oncology
- Neurological Diseases
- Psychiatry
- Others
By End User
- Hospitals & Clinics
- Research Institutions
- Academic Institutes
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/47832
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ππ ππ‘ππ«π¦πππ¨π ππ§π¨π¦π’ππ¬ market analysis from 2020 to 2030 to identify the prevailing ππ ππ‘ππ«π¦πππ¨π ππ§π¨π¦π’ππ¬ market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the ππ ππ‘ππ«π¦πππ¨π ππ§π¨π¦π’ππ¬ market size segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as ππ ππ‘ππ«π¦πππ¨π ππ§π¨π¦π’ππ¬market trends, key players, market segments, application areas, and market growth strategies.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
β’ North America
(U.S., Canada, Mexico)
β’ Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
β’ Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
β’ LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of βMarket Research Reportsβ and βBusiness Intelligence Solutions.β AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.